Fibrinogen Market

Fibrinogen (factor I) is a glycoprotein in vertebrates that helps in the formation of blood clots. Fibrinogen Concentrate is used as a medicine for blood disease. Fibrinogen concentrate is a preparation of coagulation factors prepared from pooled plasma. Currently, only RiaSTAP (CSL Behring) is licensed in a number of countries for multiple indications including treating acute bleeding episodes with Hypofibrinogenemia. Other manufacturer?s products are justly used in local region or countries.

Fibrinogen Market contains market size and forecasts of Fibrinogen in global, including the following market information:

Global Fibrinogen Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Fibrinogen Market Sales, 2017-2022, 2023-2028, (Kg)

Global top five Fibrinogen companies in 2021 (%)

The global Fibrinogen market was valued at 819.7 million in 2021 and is projected to reach US$ 2133.3 million by 2028, at a CAGR of 14.6% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Human Fibrinogen Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Fibrinogen include CSL Behring, LFB Group, Shanghai RAAS Blood Products, Jiangxi Boya Bio-Pharmaceutical, Hualan Biological Engineering, Harbin Pacific Biopharmaceutical, GREEN CROSS, Shanghai XinXing Medical and Taibang Biologic and etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Fibrinogen manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Fibrinogen Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Kg)

Global Fibrinogen Market Segment Percentages, by Type, 2021 (%)

Human Fibrinogen

Animal Fibrinogen

Global Fibrinogen Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Kg)

Global Fibrinogen Market Segment Percentages, by Application, 2021 (%)

Congenital Fibrinogen Deficiency

Surgical Procedures

Others

Global Fibrinogen Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Kg)

Global Fibrinogen Market Segment Percentages, By Region and Country, 2021 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Fibrinogen revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Fibrinogen revenues share in global market, 2021 (%)

Key companies Fibrinogen sales in global market, 2017-2022 (Estimated), (Kg)

Key companies Fibrinogen sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

CSL Behring

LFB Group

Shanghai RAAS Blood Products

Jiangxi Boya Bio-Pharmaceutical

Hualan Biological Engineering

Harbin Pacific Biopharmaceutical

GREEN CROSS

Shanghai XinXing Medical

Taibang Biologic

Octapharma